When was Acclarent founded?

Acclarent was founded in 2004 and raised its 1st funding round 1 year after it was founded.

Where is Acclarent located?

Acclarent is headquartered in Irvine, United States. It is registered at 33 Technology Dr, Irvine, CA 92618, United States.

How many employees does Acclarent have?

As of Aug 31, 2026, the latest employee count at Acclarent is 173.

Is Acclarent a funded company?

Acclarent is a funded company, having raised a total of $61M across 3 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Dec 27, 2005.

When was the latest funding round of Acclarent?

Acclarent's latest funding was a $***** Series D round on Jan 12, 2009, with participation from 5 investors.

Where does Acclarent rank among its competitors?

Acclarent ranks 4th amongst 11 active competitors, of which 4 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Tivic Health, which secured $28.3M in Dec, 2025.

Who are the top competitors of Acclarent?

Acclarent's top competitors include Intersect ENT, Tivic Health and Entellus Medical. Among them, Tivic Health secured the most recent funding round in December, 2025.

Acclarent - 2026 Company Profile, Team, Funding & Competitors

Acclarent is an acquired company based in Irvine (United States), founded in 2004 by Joshua Makower and John Chang. It operates as a Developer of a balloon-based sinuplasty technology. Acclarent has raised $61M in funding from Meritech. The company has 11 active competitors, including 4 funded and 5 that have exited. Its top competitors include companies like Intersect ENT, Tivic Health and Entellus Medical.

Company Details

Developer of a balloon-based sinuplasty technology. The company is dedicated to supporting Ear, Nose, and Throat surgeons with minimally invasive technologies designed to preserve nasal anatomy, while addressing rhinosinusitis and persistent Eustachian Tube Dysfunction.

Website: acclarent.com
Part Of
Registered Address: 33 Technology Dr, Irvine, CA 92618, United States

Key Metrics

Founded Year

2004

Location

Irvine, United States

Stage

Acquired

Total Funding

$61M in 3 rounds

Latest Funding Round

Series D, Jan 12, 2009, $*****

Investors

Meritech & 5 more

Ranked

4^th among 11 active competitors

Employee Count

173 as on Aug 31, 2026

Similar Companies

Intersect ENT & 12 more

Exit Details

Acquired by Integra LifeSciences (Dec 13, 2023)

View Acclarent's full profile

Acclarent is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Acclarent, Inc CIN: 201772549 , United States, Active	Jun 06, 2004	-	349 (As on Dec 31, 2011)	-

Acclarent got acquired by Integra LifeSciences on Dec 13, 2023 at an acquisition amount of $*****.

Click here to take a look at Acclarent's acquisition in detail

Acclarent has raised a total funding of $61M over 3 rounds. Its first funding round was on Dec 27, 2005. Its latest funding round was a Series D round on Jan 12, 2009 for $*****. 5 investors participated in its latest round. Acclarent has 6 institutional investors.

Here is the list of recent funding rounds of Acclarent:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 12, 2009	8067442	Series D	5526953	5534269	6595298	8634812
Apr 23, 2007	9175073	Series C	5311077	9087328	6725908	Delphi Ventures & 2 more
Dec 27, 2005	1149684	Series B	5765036	1551765	2575680	5828556

Access funding benchmarks and valuations. Sign up today!

View details of Acclarent's funding rounds and investors

The founders of Acclarent are Joshua Makower and John Chang.

Here are the details of Acclarent's key team members:

Joshua Makower: Co-Founder & Chairman of Acclarent and founder of 1 other company. They serve on the boards of 2 companies.
John Chang: Co-Founder & VP of Acclarent and founder of 1 other company.
Contact Info: 1 email address

View details of Acclarent's Founder profiles and Board Members

Acclarent's employee count trend

Acclarent has 173 employees as of Aug 26. Here is Acclarent's employee count trend over the years:

Uncover Acclarent's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Acclarent include Intersect ENT, Tivic Health and Entellus Medical. Here is the list of Top 10 competitors of Acclarent, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Intersect ENT 2003, Menlo Park (United States), Acquired	Developer of drug releasing implant to treat sinusitis	$76.5M	Medtronic, Norwest & 13 others	54/100
2nd	Tivic Health 2016, Menlo Park (United States), Public	Developer of a bioelectronic medical device for the treatment of sinusitis	$8M	HBS Alumni Angels Association, Lateral Frontiers ... & 14 others	51/100
3rd	Entellus Medical 2006, Plymouth (United States), Acquired	Developer of suite of products for treating chronic sinusitis	$90.5M	Greenspring Associates, EW Healthcare Partners ... & 4 others	48/100
4th	Acclarent 2004, Irvine (United States), Acquired	Developer of a balloon-based sinuplasty technology	$61M	Meritech, Versant Ventures & 4 others	47/100
5th	MyPurMist 2001, Concord (United States), Seed	Natural steam inhalers and air purifiers for respiratory relief	$8.89M	Keiretsu Forum, Band of Angels & 2 others	47/100
6th	Dalent Medical 2017, Coral Gables (United States), Seed	Developer of balloon-based sinus dilation device	$3.45M	Miami Angels, Verve Capital & 3 others	42/100
7th	Jeder System 2010, Vienna (Austria), Acquired	Minimally invasive sinus lift system	$1.22M	tecnet equity, Austria Wirtschaftsservice ... & 1 others	30/100
8th	Sinusafe Medical 2015, Kiryat Ono (Israel), Funding Raised	Medical device for sinus lavage	-	Incentive Incubator, Peregrine Ventures	27/100
9th	SinuSys 2010, Palo Alto (United States), Series D	Sinus Dilation Made Simple	-	Emergent Medical Partners, AshHill	27/100
10th	ST Stent 2013, Misgav (Israel), Seed	Flexible nasal stent	$450K	EIC Fund, Katao & 1 others	24/100